NEW YORK, Dec. 5 /PRNewswire-FirstCall/ -- The Board of Directors of
Bristol-Myers Squibb Company (NYSE: BMY) today declared a quarterly
dividend of twenty-eight cents ($0.28) per share on the $.10 par value
Common Stock of the corporation. The quarterly dividend will be payable on
February 1, 2007 to stockholders of record at the close of business on
January 5, 2007.
The Directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable March 1, 2007 to stockholders of record at the close of business on
February 2, 2007.
As previously announced, the Board of Directors has indicated an
expected dividend for the full year of 2007 of $1.12 per share, subject to
the normal quarterly review by the Board. The indication is also subject to
the outcome of the pending PLAVIX(R) patent litigation scheduled to
commence on January 22, 2007 and the absence of sustained generic
competition for PLAVIX(R) in 2007.
Bristol-Myers Squibb Company is a global pharmaceutical and related
health care products company whose mission is to extend and enhance human
life.
SOURCE Bristol-Myers Squibb Company
 back to top
Related links:
http://www.bms.com
CONTACT:
Media, Jeff Macdonald, Communications,
+1-212-546-4824, jeffrey.macdonald@bms.com; or Investors, John
Elicker, Investor Relations, +1-212-546-3775,
john.elicker@bms.com
|
